Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New aneurysm repair technology used for first time in Canada in Montreal

23.06.2003


Physicians at the Montreal Neurological Institute and Hospital are using a new technology to treat patients with brain aneurysms. Matrix© coils provide better stabilization of the aneurysms and promote faster healing of the lesion. So far, two patients have received the Matrix© coil treatment at the MNI/H. The Montreal Neurological Institute and Hospital is one of three centres in Canada chosen to use the new Matrix© coil. The others are Toronto Western and Foothills Hospital in Calgary.



“Our team is very excited to be able to offer this new technology to our patients,” explained Dr. Donatella Tampieri, Director of Diagnostic and Interventional Neuroradiology at the MNI/H. “This improvement in coil technology - a bioactive coated coil - occludes the aneurysm and promotes a faster and better organized clot preventing re-opening”.

Aneurysms are a weakening in the blood vessel wall which causes bulging. Aneurysms often remain without symptoms for a long time. A ruptured aneurysm will cause bleeding in the brain leading to brain damage and possibly death.


Physicians at the MNI/H treat more than 100 aneurysms per year and 40 of those are treated with coils.

The new Matrix© coated coil is designed to enhance the formation of the clot and seal the aneurysm. Although coil technology has been around for 13 years, the coated coil was developed in the last two years by a team from UCLA and has been successfully used in 400 patients worldwide. The Matrix© coil is manufactured by Boston Scientific.

Dr. Tampieri works closely with neurosurgeons, Dr. Denis Sirhan and Dr. David Sinclair and neuroanesthesiologists to bring improved treatments to patients with cerebrovascular diseases. In addition to the Matrix© coil, Dr. Tampieri and her team are also using a new stent technology to treat otherwise inoperable aneurysms. “These advanced technologies open new frontiers in the treatment of complex brain vascular lesions,“ said Dr. Tamperi ”As a leading neurological centre, The Montreal Neurological Institute and Hospital continues to bring the latest treatments to our patients thanks to an integrated team effort requiring close co-operation of physicians, nurses, x-ray-technologists and managers.


The McGill University Health Centre (MUHC) (http://www.muhc.mcgill.ca/) is a leading Canadian academic hospital, providing tertiary care for difficult and complex conditions as well as providing primary and secondary care to patients of all ages. It receives a million ambulatory patient visits each year and 40,000 in-patient stays. The MUHC Research Institute is the largest medical research centre of its kind in Canada. The original partner hospitals of the MUHC are the Montreal General, the Royal Victoria, Montreal Chest, Montreal Neurological and Montreal Children’s Hospitals


The Montreal Neurological Institute (www.mni.mcgill.ca) is a McGill University (www.mcgill.ca) research and teaching institute, dedicated to the study of the nervous system and neurological diseases. Since its founding in 1934 by the renowned Dr. Wilder Penfield, the MNI has helped put Canada on the international map. It is one of the world’s largest institutes of its kind; MNI researchers are world leaders in biotechnology, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders.


For further information or to interview Dr. Tampieri, please contact:

Dr. Sandra McPherson
Montreal Neurological Institute
Tel: (514) 398-1902
Fax: (514) 398-8072
Email: sandra.mcpherson@mcgill.ca

Sandra McPherson | McGill University
Further information:
http://www.mni.mcgill.ca/announce/tampieri_e.htm
http://www.bostonscientific.com/

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>